Valuation: DiaSorin S.p.A.

Market Cap 3.7B 4.21B 3.4B 3.17B 5.98B 400B 6.1B 40.93B 15.86B 197B 15.81B 15.47B 684B P/E 2026 *
20.3x
P/E 2027 * 17.7x
Enterprise Value 4.37B 4.98B 4.02B 3.75B 7.07B 473B 7.21B 48.39B 18.75B 232B 18.69B 18.29B 809B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.25x
Free-Float
-
Yield 2026 *
1.87%
Yield 2027 * 1.95%
1 day+2.95%
1 week+4.93%
Current month+2.95%
1 month+4.21%
3 months+14.14%
6 months+1.66%
Current year+1.66%
1 week 66.36
Extreme 66.36
70.32
1 month 62.96
Extreme 62.96
75.3
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.93%-23.89%-26.88% 4.1B
+13.82%+24.69%+236.76%+377.01% 19.89B
+2.04%+2.86%-40.24%-27.07% 9.26B
-1.78%+3.92%+37.19%+29.84% 7.22B
+5.22%+3.31%-29.27% - 5.04B
+4.31%+5.06%-22.39%-25.75% 4.86B
+1.85%+12.86%+223.80%-30.07% 4.87B
-1.64%+2.16%+89.84%+97.44% 4.35B
+3.03%+0.13%-20.14%-42.20% 2.44B
+6.11%+7.08%-25.28%-9.26% 1.22B
Average +3.59%+4.49%+42.64%+38.12% 6.33B
Weighted average by Cap. +5.64%+7.42%+89.36%+127.00%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.05B 1.98B 133B 2.02B 13.58B 5.26B 65.21B 5.25B 5.13B 227B 1.31B 1.49B 1.2B 1.12B 2.11B 141B 2.16B 14.46B 5.6B 69.45B 5.59B 5.47B 242B
Net income 183M 208M 168M 157M 296M 19.78B 302M 2.02B 784M 9.71B 781M 764M 33.8B 206M 235M 190M 177M 334M 22.34B 340M 2.28B 885M 10.96B 882M 863M 38.16B
Net Debt 674M 768M 620M 578M 1.09B 72.99B 1.11B 7.46B 2.89B 35.83B 2.88B 2.82B 125B 543M 618M 500M 466M 878M 58.8B 896M 6.01B 2.33B 28.86B 2.32B 2.27B 100B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-07-01 €69.76 +2.95% 212,969
26-06-30 €67.76 -3.14% 238,260
26-06-29 €69.96 +2.37% 331,777
26-06-26 €68.34 +2.92% 208,577
26-06-25 €66.40 -0.12% 239,419
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
69.76EUR
Average target price
70.52EUR
Spread / Average Target
+1.09%

Quarterly revenue - Rate of surprise